Anika Therapeutics Inc (ANIK) earnings · rev $112.8M
These earnings events as JSON? API free 100/dayAnika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
This ANIK earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ANIK revenue for 2025-12-31 was $112.8M. Net income was -$10.9M. Revenue was down 5.9% from 2024-12-31 to 2025-12-31. ANIK currently screens at market cap $161.3M.
When the next ANIK 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 5.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ANIK research stays on the stock page; the tape stays on the quote page.
ANIK earnings FAQ
What are ANIK's latest revenue and net income?
Latest cached Anika Therapeutics Inc (ANIK) revenue for Dec 31, 2025 was $112.8M. Net income was -$10.9M. Statements: https://lician.com/financials/anik
What is ANIK's latest diluted EPS?
Latest cached Anika Therapeutics Inc (ANIK) diluted EPS for Dec 31, 2025 was -$0.76.
What period does the latest ANIK earnings print cover?
The latest cached Anika Therapeutics Inc (ANIK) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ANIK revenue change from the prior cached period?
Cached Anika Therapeutics Inc (ANIK) revenue was down 5.9% from $119.9M (Dec 31, 2024) to $112.8M (Dec 31, 2025). Statements: https://lician.com/financials/anik
Where are ANIK earnings listed?
Cached earnings facts for Anika Therapeutics Inc (ANIK) are listed at https://lician.com/earnings/anik. Statements: https://lician.com/financials/anik
Not investment advice.